Author

Shuo Li

Tianjin Medical University Cancer Institute and HospitalORCID 0000-0001-9804-8448Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Shuo Li3 papers · Shandong University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:scATAC-seq· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Beibei YangiD· 1 shared Bin WangiD· 1 shared Bo SuniD· 1 shared Fan Yu LiniD· 1 shared Hong Shu LiuiD· 1 shared Jian LiuiD· 1 shared Shasha LiuiD· 1 shared Wenting XiangiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Beibei YangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Single-Cell RNA and ATAC Sequencing Reveal Cellular Heterogeneity and Chromatin Accessibility Dynamics in Young Chinese Breast Cancer Patients across Pre- and Post-Neoadjuvant Therapy

Xue Mei Han, Bin Wang, Wenting Xiang, Fan Yu Lin, Bo Sun, Beibei Yang, Zhihan Ruan, Shasha Liu, Shuo Li, Hong Shu Liu, Jian Liu

This study uses scRNA-seq and scATAC-seq to analyze cellular heterogeneity and chromatin accessibility changes in young breast cancer patients before and after neoadjuvant therapy, identifying therapy-resistant genes and signaling pathways.

bioRxiv · Oct 14, 2025 · PreprintCancer Biology